At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1 enrolled
Drug / intervention
Ulipristaldrug
Likely dose
Ulipristal 15mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase IV Pilot Study of Ulipristal Acetate for Treatment of Endometriosis-related Pelvic Pain
In Brief
A Phase 4 clinical trial evaluating Ulipristal for Endometriosis. Completed, enrolled 1 participant across 1 site.
Detailed Summary
The aim of this research is to assess the benefit of a medication (ulipristal) for alleviation of symptoms in women with chronic, endometriosis-related pelvic pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndometriosis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 2014
Enrollment StartFeb 2015
Primary CompletionNov 2016
Study CompletionDec 2016
TodayJul 2026
First PostedAug 11, 2014
Enrollment StartFeb 1, 2015
Primary CompletionNov 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.9 years ago
Interventions
Ulipristaldrug
Patient will take 15mg every other day, or every 4 days per week.